Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
about
Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuriaMaternal Phenylketonuria Collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelaeA different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyaseAn Oak Ridge legacy: the specific locus test and its role in mouse mutagenesisCarcinogenic effects in a phenylketonuria mouse modelBehavioral and neurochemical characterization of new mouse model of hyperphenylalaninemiaDifferential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) miceMouse homologues of human hereditary disease.Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.Low-Dose Gene Therapy for Murine PKU Using Episomal Naked DNA Vectors Expressing PAH from Its Endogenous Liver PromoterTissue-specific activation of mitogen-activated protein kinases for expression of transthyretin by phenylalanine and its metabolite, phenylpyruvic acid.5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria.Proteomic analysis of NME1/NDPK A null mouse liver: evidence for a post-translational regulation of annexin IV and EF-1Bα.Transgene-induced mutation of the murine steel locusMouse models of human phenylketonuria.Efficient recovery of ENU-induced mutations from the zebrafish germline.Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)An olfactory discrimination procedure for mice.Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivoLow bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.Pathologic and immunohistochemical findings in hypothalamic and mesencephalic regions in the pah(enu2) mouse model for phenylketonuria.The role of the laboratory mouse in the human genome projectGlycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.Preparation and evaluation of a novel therapeutic dairy-based drink for phenylketonuriaNutritional management of PKU with glycomacropeptide from cheese whey.sar: a genetic mouse model for human sarcosinemia generated by ethylnitrosourea mutagenesisGene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.Progress toward cell-directed therapy for phenylketonuria.Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria.Expression of phenylalanine hydroxylase (PAH) in erythrogenic bone marrow does not correct hyperphenylalaninemia in Pah(enu2) mice.Forward and reverse genetic approaches to behavior in the mouse.Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?Early-onset behavioral and neurochemical deficits in the genetic mouse model of phenylketonuriaAdministration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.In vitro injury model for oligodendrocytes: development, injury, and recovery.Cardiovascular defects among the progeny of mouse phenylketonuria females.
P2860
Q28216391-32DF9A29-A44C-4FE0-B678-4CD3EEE26828Q28305668-56F09143-F10E-4A51-84BB-40E5D34E6505Q28343191-B79BA543-E653-4BA0-B72E-170BE01874A0Q28379338-4D67B0BA-3F2E-4653-92DF-DE0500C3E0CCQ28474582-85F61F12-7ED6-4001-953E-310419BAAB06Q28537886-8B148474-8686-4CDD-B68A-EFB49BC1F161Q30415470-E70EE404-3FC8-40C5-AF92-22F739E0474AQ30495383-D23CE8A2-8CBF-4C2B-8107-0E965EAC883EQ33617709-369C9365-9695-4435-AEF8-CE61742D1B99Q33652430-5810BBD3-9BF2-48DC-A8AA-B36640FF865BQ33685119-B9148D01-083F-4C52-880B-0328573BB192Q33735421-68C138CA-A988-4D96-92C7-0175B5173B69Q33889579-7ED71F59-B269-43F9-BC82-520D9C7B71FFQ33927926-933C25BD-3C12-404E-8616-002F4CC2D117Q33961407-2E736949-69C4-4D50-88AC-0B527EB5370CQ33962803-CFFCFAAE-D8B7-4CB9-9628-A722EF9E17F8Q33993821-1BD05B35-9163-42A7-B25C-2320A823D6B9Q34136453-680A6186-8385-49DF-990B-43246FDDDB87Q34392517-6DDE8D26-9273-47EA-9C7F-6079F72D1B46Q34428243-CF3CC95B-DC9F-4688-BB68-B670093F51F0Q35739492-11FD1C99-CBAF-4C81-932C-A3F44F2A98D0Q35810261-F15BE95C-8EAB-4598-8B2B-C23604FC14E7Q35882117-3648269B-A494-45C7-B933-399F65D499CEQ35900593-BED663C6-B018-42BC-9CF2-13721DC1CEB8Q35966561-0218B635-5A2E-4343-89B6-5D7C098C47B4Q36786748-ACF23D84-3151-403B-B0A7-E70DE15CB80CQ36913777-E20E5AF9-5759-43AD-B2D6-34C155E88F71Q37127238-FC14F324-6F91-489C-A4DA-9408C6F96E3FQ37170974-34F182E5-7560-4717-A9F3-3D5F515CD211Q37221675-9275792B-8B29-4DAD-8BCF-21FB7FBB503AQ37221695-5FE84BEB-BB26-4241-8C3F-07B896208F23Q37316585-216999E6-FDFD-41BA-A40B-BA1C9A0479B2Q40859199-DD885593-B970-49E4-9196-0959A130D52BQ41544887-B6224043-9582-4C84-A322-622BBEA32133Q45422040-77F30C58-BC1C-4A1C-8BB9-213737B991E5Q47866109-CB04DEB7-C5D0-48EE-BB66-A3A44109A292Q51968240-13D55ED8-046A-4633-9AB1-FDEEB5BED4F4Q52193955-7ABAC2B4-CC36-4B5F-B777-A0D508A21AD8
P2860
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
description
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1990
@ast
im März 1990 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1990/03/01)
@sk
vědecký článek publikovaný v roce 1990
@cs
wetenschappelijk artikel (gepubliceerd op 1990/03/01)
@nl
наукова стаття, опублікована в березні 1990
@uk
name
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@ast
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@en
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@nl
type
label
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@ast
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@en
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@nl
prefLabel
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@ast
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@en
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@nl
P2093
P2860
P356
P1476
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase
@en
P2093
A. Shedlovsky
J. D. McDonald
V. C. Bode
W. F. Dove
P2860
P304
P356
10.1073/PNAS.87.5.1965
P407
P577
1990-03-01T00:00:00Z